Towards a “4I” approach to personalized healthcare by Philip R O Payne & Clay B Marsh
Payne and Marsh Clinical and Translational Medicine 2012, 1:14
http://www.clintransmed.com/content/1/1/14COMMENTARY Open AccessTowards a “4I” approach to personalized
healthcare
Philip R O Payne1* and Clay B Marsh2,3Abstract
Personalized healthcare holds the promise of ensuring that every patient receives optimal wellness promotion and
clinical care based upon his or her unique and multi-factorial phenotype, informed by the most up-to-date and
contextually relevant science. However, achieving this vision requires the management, analysis, and delivery of
complex data, information, and knowledge. While there are well-established frameworks that serve to inform the
pursuit of basic science, clinical, and translational research in support of the operationalization of the personalized
healthcare paradigm, equivalent constructs that may enable biomedical informatics innovation and practice aligned
with such objectives are noticeably sparse. In response to this gap in knowledge, we propose such a framework for
the advancement of biomedical informatics in order to address the fundamental information needs of the
personalized healthcare domain. This framework, which we refer to as a “4I” approach, emphasizes the pursuit of
research and practice that is information-centric, integrative, interactive, and innovative.
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The objective of personalized healthcare is to ensure that
each patient has the best clinical outcome by tailoring
both preventative measures and treatments to meet their
unique needs and characteristics. Achieving such a vi-
sion requires not only the collection and application of
the best possible data, information, and knowledge dur-
ing each patient encounter, but also, learning from each
encounter and engaging patients and their families in
the healthcare process. This vision of a learning health
care system can improve the outcomes and quality of
care for the individual patient, their family, and their
community.
An innovative and paradigm-shifting approach to con-
ceptualizing personalized healthcare has been described
by Weston and Hood using the moniker of “P4 Medi-
cine” - where it was proposed that our fundamental ap-
proach to disease prevention, diagnosis, and treatment
must transition from being a primarily reactive model to
one that is predictive, personalized, preventive and par-
ticipatory [1]. In this model, it is envisioned that our* Correspondence: philip.payne@osumc.edu
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reproduction in any medium, provided the origfundamental approach to the delivery of healthcare will
be shifted from an emphasis on treating illness to the
early and continuous prevention of disease and the pro-
motion of wellness. Furthermore, under this paradigm,
the patient becomes an integral part of the healthcare
delivery ecosystem, taking an active role in the identifi-
cation and modification of disease related risk factors,
while also assuming responsibility for critical aspects of
their ongoing care (moving from being a passive con-
sumer of clinical care to an active member of the overall
healthcare team). Unfortunately, it is widely noted that
the current healthcare delivery workflows (including es-
sential data, information, and knowledge management
methods) are not well aligned with the P4 paradigm,
thus impeding the implementation of the model [2-6].A primer on biomedical informatics and its role in
supporting “P4 medicine”
The scientific discipline of Biomedical Informatics
emerged over the last several decades as a catalyst for the
discovery, study, and delivery of innovative solutions to
data, information, and knowledge management needs in
the biomedical and healthcare domains. Biomedical Infor-
maticians use domain-specific theories and methods to in-
terpret and reason upon complex data in order to deliveris is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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multiple end-points, such as the laboratory, point-of-care,
or community settings. As can be readily ascertained, this
continuum of data, information, and knowledge manage-
ment is central to the premises underlying P4 medicine.
Unfortunately, current approaches to basic science re-
search, clinical care, and biomedical informatics are often
poorly integrated, yielding clinical decision-making pro-
cesses that do not take advantage of up-to-date scientific
knowledge [2,3,7]. There are an increasing number of sys-
tems modelling and in-silico knowledge synthesis techni-
ques that can provide investigators with the tools to
address such information needs, but their adoption and
evaluation remains an area of early and open research [4-
8]. Given increasing concerns over barriers to translating
discoveries from the laboratory to the clinic or commu-
nity, such high-throughput informatics methods are very
desirable, and in our opinion, central to the P4 paradigm
[4,7-10]. We believe that the fundamental barrier prevent-
ing such rapid and systematic translation between re-
search and clinical care is lack of unification between data
generation, as regularly occurs in the laboratory, clinical,
and community settings; and knowledge generation,
which is the fundamental pursuit of research. This lack of
unification is attributable to a number of factors, including
socio-technical and regulatory barriers, as well as a lack of
sufficiently robust and widely adopted informatics plat-
forms intended to “shorten the distance” between data
and knowledge generation [4,5].
The “4I” Approach
Building upon the P4 Medicine model and the preceding
gaps in the state of Biomedical Informatics practice, we
believe that a corresponding “4I” approach to Biomedical
Informatics at the interface of research, education, and
clinical care is needed. At a high level, this approach is
intended to achieve unrealized benefits in terms of uni-
fying data and knowledge generation as introduced earl-
ier. Our framework (Figure 1) seeks to describe a core
set of values that guides basic and applied Biomedical
Informatics science to ensure the ongoing implementa-
tion and support of P4 medicine:
Information-centric
Our focus is not simply collecting and transacting data,
but also providing appropriate context to such data to
transform it into mission-critical knowledge. As the
range of data types needed to deliver personalized
healthcare expands in complexity and size, such an
information-centric approach will require systems-level
approaches to data, information, and ultimately know-
ledge management that extend well beyond singular in-
formation systems. Such a systems-level approach is
needed to create an “information fabric” that supportsnovel research, the training of healthcare and life science
professionals, and the delivery of care both within and
beyond organizational boundaries.
Integrative
Building on the concept of information-centricity, it is
imperative that we begin to focus on approaches to
“connecting the dots” between heterogeneous informa-
tion and knowledge types in a scalable and high-
throughput manner. For example, we have large
amounts of clinical data that are collected in electronic
health records, and similarly, large amounts of genomic
data that is generated via advanced laboratory instru-
ments. However, our ability to understand the linkages
between such data types and knowledge generation in
order to improve clinical care and disease prevention is
often limited to the intuition of individual investigators.
At the same time, advances in artificial intelligence and
knowledge-based system design as applied to biomedi-
cine can allow computational agents to reason across
such data types and simultaneously mine the available
literature and other knowledge resources. As an out-
come of this activity, a large number of testable hypoth-
eses that can inform important clinical evidence in
support of personalized healthcare can be generated and
tested.
Interactive
While computers have immense capabilities of collect-
ing, storing, and analyzing large amounts of data and in-
formation, their ability to identify and assess important
patterns in these datasets is limited. In comparison,
humans have unique and presently non-reproducible
cognitive strengths in the area of pattern recognition
and high-level problem solving. As a result, any ap-
proach to leveraging Biomedical Informatics in the con-
text of a complex environment presented by the practice
of personalized healthcare, must involve an optimal
combination of both human and computational work-
flows. Unfortunately, the area of human-computer inter-
action in the biomedical domain remains immature,
with a primary focus being placed more on technical
solutions to informatics needs, rather than the user ex-
perience. Therefore, we need to better develop and apply
such approaches in order to improve the ability of
researchers, educators, clinicians, patients, and their
families to use advanced information technology plat-
forms informed by advances in Biomedical Informatics.
Innovative
Finally, and perhaps most importantly, we must continue
to “push the envelope” of Biomedical Informatics
innovation in order to create new solutions to the pro-
blems constantly emerging throughout the complex
Figure 1 Conceptual model for the "4I” approach to P4 Medicine. In this model, the traditional separation of clinical care and research
employing a linear approach to knowledge translation evolves to support the unification of data and knowledge generation. This model involves
the shifting of Biomedical Informatics foci from current trends involving solution that are: 1) data focused; 2) specific to application areas (e.g.,
silos aligned with basic and clinical research or clinical care); 3) implemented using an engineering approach to the user experience which values
function over form; and 4) that regularly leverages existing technologies; to a new paradigm supported by four core values: 1) information-
centricity; 2) integration; 3) interactivity, and 4) innovation.
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Biomedical Informatics clearly illustrates that almost
every innovative solution to a fundamental data, infor-
mation, or knowledge management problem in the bio-
medical and healthcare domains leads to more questions
and possibilities for advancing the field. Therefore, we
must not be satisfied with the theories, methods, and
tools we currently have in our Biomedical Informatics
“tool box”, but instead, should constantly seek new ave-
nues of innovation. Doing so will also require the cre-
ation of partnerships and funding models capable of
supporting such innovation, particularly given the nearly
tectonic shifts occurring in our national research
enterprise.
Discussion
In order to further contextualize and illustrate the po-
tential benefits of the proposed “4I” approach to perso-
nalized healthcare, in the discussion below, we provide a
exemplary P4-focused use case, and then compare andcontrast Biomedical Informatics approaches to addres-
sing that use case’s information needs and implemented
based upon:
 Contemporary trends in Biomedical Informatics
practice that tend to emphasize the implementation
of solutions that are: 1) data focused; 2) specific to
application areas (e.g., silos aligned with basic and
clinical research or clinical care); 3) designed using
an engineering approach to the user experience
which values function over form; and 4) leverage
existing technologies; and
 The principles and values that underlie the proposed
“4I” approach, representing an ideal future state for
such data, information, and knowledge management
solutions.
Use case
A large academic healthcare center (AHC) seeks to pilot
the targeted sequencing of patient genomes in order to
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of care. As part of this project, the AHC intends to in-
form such decision support rules using knowledge gen-
erated via current basic science investigations, and then
study the impact of such interventions on patient out-
comes and quality/safety of care.
Contemporary biomedical informatics solutions
addressing this use case
Patient samples will be sequenced, and the resulting data
sets processed using available analytical tools informed
by the current pharmacogenomics knowledge base in
order to identify clinically relevant markers in each indi-
vidual’s genomes. Such synthesized results are reported
in an aggregate format, indicating the patients risk’s of
adverse drug reactions and/or the potential usefulness of
genetically targeted therapies (if applicable). Given the
limitations of common, commercial EHR platforms, this
report is stored as a PDF file and attached to the individ-
ual patients electronic medical records. During clinical
encounters, providers are alerted to the presence of this
report and encouraged to use it when considering thera-
peutic options for the patient. Subsequently, a combin-
ation of data analytics targeting discrete variables of
interest as well as the semi-automated review of clinical
notes, is conducted for patients involved in the pilot, in
order to determine what impacts the availability of the
aforementioned genomic data had on patient outcomes
and quality/safety of care in a retrospective manner.
“4I”-Based biomedical informatics solutions addressing
this use case
Patient samples will be sequenced, and the resulting raw
data stored in a distributed data repository that is appro-
priately tuned for the storage and retrieval of “big data.”
During a given patient encounter, should a medication
order be entered, a real time process will: 1) determine if
genomic data is available for the patient; 2) query a dy-
namic knowledge base consisting of expertly curated
rules as well as rules extracted through the periodic pro-
cessing and analysis of available bibliographic data sets,
in order to identify potential correlations between the
medication being considered by the clinician and avail-
able and current pharmacogenomc knowledge; 3) apply
those rules to the patient’s unique genomic and pheno-
typic variables; and 4) generate a point-of-care alert with
recommendations based on the preceding analysis. If the
this process is invoked as described, the patient’s records
would also be flagged, and a regularly occurring analyt-
ical “agent” would analyze near, medium, and long term
patient outcomes and quality/safety of care indicators,
and present such analyses in a dashboard format avail-
able to patients, clinicians, and researchers involved in
the project. Finally, all of the aforementioned measureswould be designed and implemented based on exhaust-
ive end-user focused human factors and workflow ana-
lyses, intended to optimize workflow integration and
user experience for all stakeholders.
Conclusion
We believe that the preceding vision of P4 Medicine and
the “4I” approach is both essential and critical to ad-
vance the state of healthcare in a manner that increases
quality and safety while reducing costs and increasing
patient access. However achieving this vision will require
major changes in our approach to data, information, and
knowledge management, particularly with regard to uni-
fying such activities. As such, we argue that a “4I” ap-
proach to address the foundational information needs of
P4 Medicine, based upon the core values of information
centricity, integration, interactivity, and innovation, is of
the utmost importance. In presenting these views, we
hope to catalyze a vigorous dialogue concerning the de-
velopment of a Biomedical Informatics research and de-
velopment roadmap that is closely aligned with that of
the P4 Medicine paradigm.
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